Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Monthly progress report on CSE for IN Quote :
"The Company welcomes such a positive response from the investment community," stated Eric A. Adams, President & CEO, "We are very pleased to be in a position to close the financing, on an oversubscribed basis, so quickly. With this financing, InMed is well positioned with a strong balance sheet to continue to execute on corporate objectives. We have significantly extended the cash runway for our lead programs, INM-750 for EB and biosynthesis, and will be able to make significant advancements for both INM-085 for glaucoma and INM-405 for pain." The Company also intends to use the net proceeds from the private placement for general working capital and corporate purposes, and to seek a listing of its common shares on the Toronto Stock Exchange.
http://thecse.com/sites/default/files/CNSX_Form_7_-_Monthly_Progress_Report_Jan_2018.pdf
Wow!... sure a ton of panic here. This stock gapped up way too much in the last two weeks. The company has NOT sold out with plenty of options left to play. I’m waiting for something big here and will happen with enough patience. Congrats to the ones with the “Balz” to trade this short term... I’m “IN” for the long term and sure this current chaos was done for a reason we’ll all see soon enough. GLTA
Eric Adams still has plenty of options that haven’t been exercised @ .08 & .11. Perhaps they’re doing another financing that the staff are going to participate in...then things would make sense. They are in San Francisco for something...
I don’t know exactly. According to Sedi report I looked at his account is dry. But he has at least 4 million options unexercised that don’t expire until 2021.
Disappointed in Eric Adams and co. I understand taking a small bonus, but the amount Eric cashed out was insulting to us long term shareholders. I thought these schemes were done with this company. I’m still a believer and hanging in for the long term, but feel a little sick drinking my coffee right now. (Perhaps a shot of Baileys will help)
LMFAO who are the geniuses running the U.S. exchange? The IN has been halted in Canada since 6 minutes into trading. Not sure why you guys are still open??!!
Any speculation out there for the reason for the Halt? Hopefully an early x-mas present :)
On what basis is this prediction of such a big jump in share price? Think a partnership is coming or news on Biosynthesis? Hope your thoughts come true :) But be prepared to wait a little longer... it’ll be worth it! Cheers
All I know this was distributed widely. Not going anywhere, this latest pump cost the company huge. Only makes sense if a biggie news release follows... then we’re over the dollar!... and funds take over!
As frustrating as it is waiting for EB inm750 to go to trials... this company has a financial security that its’ working on first and foremost. The rest will come in time.
Not at all!
Financing (pp private placement). Was big and strong in the last couple of presentations if you follow Inmed website presentations.
https://www.inmedpharma.com/site/assets/files/1423/2017-11-20-cp_in.pdf
Noticeably absent from this presentation is latest pp which has been included with latest ones. Nice new content.
You only buy more on dips and improve your position, if you’re serious about this investment. Then forget about it ;)
I’ve been “IN” and out of this this stock since their ipo. When I really did my research and saw what was going on, I started loading up. I don’t care about time now. I have an average price of .20 CDN and enough shares to make me very rich;) I’m not selling until this stock is over $50, which will take a few years... but I’m glad to sit and wait... in the meantime close yours eyes and buy more on the dips!
Exactly! We think it’s worth more... because we’re believers! Quite honestly my heart sinks every time EB trials gets delayed. I hope the “Big Money” is in Biosynthesis and makes this company a self funding model. But I want EB to go to trials and end the suffering of these poor kids... not too mention the changes to dermatology as a whole if this drug really works!
It’s unsubstantiated. This company is only hopes and dreams at this point. We need something tangible to justify its’ worth. What are your thoughts?
We might not get any news at all... that’s my point... then the slow drift back down. Don’t despair, just means more buying opportunity for those wanting too load. Personally I hope we have a substantial NR... but I’ve seen these tricks before.
This ballistic move up has been very exciting this week but unsubstantiated. Unless we see some “real” news soon, what goes up - must go down!
Good find Shake n Bake!
... And perhaps run it as a separate company that could make the possibility of Partnership more viable. Didn’t Bogart just delist Sgh from the Venture and apply for the CSE? Looks like a perfectly good “shell” to me!
Awesome! Thanks :)
Ran into the same block. I know we’re good on this investment... nothing I really need to see :)
I think a partnership is most likely. Why else assemble the best of the best for scale-up of Biosynthesis if they didn’t have a long term interest mindset?
Why have Big Pharma buy you out?...When you can BE Big Pharma???? I think these guys have got this all figured out :)
Serious investors do their DD on these companies, probably the thing I like the most about CSE listed stocks in Canada is the huge amount of disclosure these companies have to file. Inmed certainly has a long history of “questionable” antics, which would be a Red Flag to most. I have my own theory on recent sell-off... might be way off base... but helps me sleep at night ;) I’m still confident in the future of this company.
Still looks bad on the company when Directors (Gardner) and Founding members (Sazzad) start unloading while putting all these expensive “pumps” out. The interview today was pretty good... wonder who is unloading today? http://www.cannabisfn.com/inmed-pharmaceuticals-biosynthesis-platform-results-industry-first/
Opinion appreciated!
Health Canada certainly has been lagging on their approvals for licences, which will make “supply and demand” rather difficult to fill. I’m curious if Inmed requires a licence for commercial production of their cannabinoids? Anybody know?
I think this is close to the lowest we’ll see the pp on Inmed. The financing has to close first... so maybe one more blow-out. But I have high hopes that a big announcement is coming soon?! With the publishing of the 085 results.
When so... as I believe talks have been happening... some good backing will put the pp in the dollars and let this stock upgrade in their listings.
Shorts will stop when financing is done!
Well, you answered a huge amount of the question already(dilution). This drug will cost a lot too Inmed to bring through clinical trails. A big company coming in now will have access to dispersing this drug and production. This will strengthen Inmeds’ credibility and deliver well needed funds to make this company a big player with a couple of drugs coming out of the pipeline. The company can only bring one out at a time... why not have two strongly going through the pipeline at once? Biosynthesis will only grow on the results 075 & 085 bring. Inmed will be self funding company soon we hope... but a logical sell-off of an amazing formula that they seem to have “locked in” seems a very good move.
Like I said before in hope... a “bought-deal” financing with the new partner for Inm-085. I’m sure they have a suitor or two lined up!
I don’t believe anything substantial will happen here until the last financing is done. Then hopefully a news release indicating a partnership in Glaucoma or Biosynthesis...that’s when this stock will move and the fun begins!
See you all here in the morning...bright & sharp. Thanks for your DD Flair09. Hopefully we have some “good times” ahead!
Of course the PR you received does sound like our company. Let’s see what comes out and who paid for it. Hopefully this is on the heels of a real news release and not the “nauseating” PR that we’ve all become accustomed too. I know something will become of this company eventually.